New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For FLR;KBR;JEC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
10:01 EDTKBROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:48 EDTJECJacobs Engineering announces $300M in total contracts over past six months
Subscribe for More Information
05:48 EDTKBRKBR downgraded to Hold from Buy at Jefferies
Subscribe for More Information
February 27, 2015
07:08 EDTKBRKBR sees FY15 EPS ex-items $1.07-$1.22, consensus $1.16
2015 is expected to be a transition year for KBR as the company implements its strategy to focus on the global hydrocarbons and international government services markets. KBR will continue its efforts to exit non-strategic businesses and to reduce operating costs. The company also plans to continue efforts to obtain negotiated resolutions of ongoing commercial disputes and will continue to defend against unjustified claims. KBR currently forecasts 2015 legal costs associated with legacy U.S. Government contracts to range from $18M-$25M. Excluding these legacy-related costs, the company expects 2015 fully diluted EPS to be in the range of $1.07-$1.22.
07:07 EDTKBRKBR reports Q4 EPS ($8.57), may not compare to consensus 21c
Subscribe for More Information
February 25, 2015
16:28 EDTFLRFluor wins natural gas development contract in Brazil
Fluor's CFPS Engenharia e Projetos, S.A., consortium with Construcap Engenharia e Comércio was awarded an engineering and design contract by exploration and production company Parnaíba Gás Natural for a natural gas field development project in the Parnaiba Basin in Maranhão state in Brazil. Fluor booked its share of the contract for an undisclosed value in Q1.
February 24, 2015
07:46 EDTJECJacobs Engineering awarded contract from Bristol-Myers
Jacobs Engineering Group (JEC) announced that it received a contract from Bristol-Myers Squibb Company (BMY) to provide architectural and engineering services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland. The facility is being designed to produce multiple therapies for the company’s robust and growing portfolio of approved and investigational biologic medicines, and to increase Bristol-Myers Squibb’s biologics manufacturing capacity. The new facility is expected to include multiple large scale bioreactors, a purification area, as well as office and laboratory space. Bristol-Myers Squibb’s Board of Directors has approved initial funding that will support the first phase of the project, with the full cost of the facility expected to be finalized in the second half of 2015. The facility is estimated to be operational in 2019.
07:25 EDTJECRW Baird to hold a conference
Subscribe for More Information
February 20, 2015
09:37 EDTKBRKBR awarded ammonia plant EPC contract
KBR announced that it has executed an EPC contract with Yara International and BASF Group's new joint production company to provide ammonia synthesis licensed technology and engineering, procurement and construction to build a world-scale ammonia plant at BASF's site in Freeport, Texas. Expected revenue from the contract will be included in Q1 backlog for KBR's Engineering and Construction segment.
February 19, 2015
09:31 EDTFLRFluor reported 'impressive' results, says Sterne Agee
Subscribe for More Information
08:40 EDTKBRKBR, Showa Denko sign multi-technology acetyls licensing agreement
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use